[Mode of action of immunoprevention in anti-Rh-induced haemolytic disease of newborn infants].
D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007231:Infant, Newborn; D011247:Pregnancy
D007136:Immunoglobulins; D007166:Immunosuppressive Agents
Zur Wirkungsweise der Immunprophylaxe des Anti-Rh-bedingten Morbus haemolyticus neonatorum (M. h. n.